諾禾致源股票討論區

Novogene's positive outlook is already reflected in its fair value share trading. The optimistic prospect suggests it's worth examining other factors like balance sheet strength.

Novogene's high P/E ratio, weak earnings outlook, and slower market growth indicate a potential share price decline, posing a risk to shareholders and potential investors. Many investors seem more bullish than analysts, unwilling to sell their stock at any price.

The high P/E ratio suggests expectation of the company's strong turnaround, yet with growth below forecasted market levels, this raises concerns about the P/E ratio and potential decline of share price, risking significant shareholder investments.